IL-1β enhances the antibacterial activity of astrocytes by activation of NF-κB

GLIA

Volumn 58, Issue 2, 2010, Pages 244-252

  Yulei, Xia ^a   Qiwei, Zhai ^a  

^a Chinese Academy of Sciences   (China)

Author keywords

Escherichia coli; Glia; I B ; Translocation

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; RECOMBINANT INTERLEUKIN 1BETA; I KAPPA B; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; ASTROCYTE; BACTERIAL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MOUSE; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; TRANSACTIVATION; ACTIVE TRANSPORT; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; MOUSE MUTANT; PHYSIOLOGY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ASTROCYTES; CELLS, CULTURED; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIAL VIABILITY; NF-KAPPA B; RECEPTORS, INTERLEUKIN-1 TYPE I;

EID: 73149083707     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20921     Document Type: Article

References (30)

1. Bechmann I, Galea I, Perry VH. 2007. What is the blood-brain barrier (not)? Trends Immunol 28:5-11.
2. Beskina O, Miller A, Mazzocco-Spezzia A, Pulina MV, Golovina VA. 2007. Mechanisms of interleukin-1β-induced Ca2+ signals in mouse cortical astrocytes: Roles of store- and receptor-operated Ca2+ entry. Am J Physiol Cell Physiol 293:C1103-C1111.
3. Caamano J, Hunter CA. 2002. NF-κB family of transcription factors: Central regulators of innate and adaptive immune functions. Clin Microbiol Rev 15:414-429.
4. Chao CC, Lokensgard JR, Sheng WS, Hu S, Peterson PK. 1997. IL-1-induced iNOS expression in human astrocytes via NF-κB. Neuroreport 8:3163-3166.
5. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36:180-190.
6. Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y. 2000. Astrocytes express functional chemokine receptors. J Neuroimmunol 111:109-121.
7. Falsig J, Porzgen P, Lund S, Schrattenholz A, Leist M. 2006. The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem 96:893-907.
8. Farina C, Aloisi F, Meinl E. 2007. Astrocytes are active players in cerebral innate immunity. Trends Immunol 28:138-145.
9. Galea I, Bechmann I, Perry VH. 2007. What is immune privilege (not)? Trends Immunol 28:12-18.
10. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, Morrissey PJ. 1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 159:3364-3371.
11. Glezer I, Simard AR, Rivest S. 2007. Neuroprotective role of the innate immune system by microglia. Neuroscience 147:867-883.
12. Hao HN, Zhao J, Lotoczky G, Grever WE, Lyman WD. 2001. Induction of human b-defensin-2 expression in human astrocytes by lipopoly-saccharide and cytokines. J Neurochem 77:1027-1035.
13. Hayden MS, Ghosh S. 2008. Shared principles in NF-κB signaling. Cell 132:344-362.
14. Hayden MS, West AP, Ghosh S. 2006. NF-κB and the immune response. Oncogene 25:6758-6780.
15. John GR, Lee SC, Song X, Rivieccio M, Brosnan CF. 2005. IL-1-regulated responses in astrocytes: Relevance to injury and recovery. Glia 49:161-176.
16. Lee SC, Dickson DW, Brosnan CF, Casadevall A. 1994. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 180:365-369.
17. Liu J, Zhao ML, Brosnan CF, Lee SC. 1996. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: Role of IL-1β and IL-1 receptor antagonist. J Immunol 157:3569-3576.
18. Luo Y, Fischer FR, Hancock WW, Dorf ME. 2000. Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes. J Immunol 165:4015-4023.
19. Markiewicz I, Lukomska B. 2006. The role of astrocytes in the physiology and pathology of the central nervous system. Acta Neurobiol Exp (Wars) 66:343-358.
20. Moynagh PN. 2005. The interleukin-1 signalling pathway in astrocytes: A key contributor to inflammation in the brain. J Anat 207:265-269.
21. Nguyen MD, Julien JP, Rivest S. 2002. Innate immunity: The missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3:216-227.
22. Oberdorfer C, Adams O, MacKenzie CR, De Groot CJ, Daubener W. 2003. Role of IDO activation in anti-microbial defense in human native astrocytes. Adv Exp Med Biol 527:15-26.
23. Robinson CM, Hale PT, Carlin JM. 2006. NF-κB activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-γ and tumor necrosis factor-a. Cytokine 35:53-61.
24. Romero LI, Tatro JB, Field JA, Reichlin S. 1996. Roles of IL-1 and TNF-a in endotoxin-induced activation of nitric oxide synthase in cultured rat brain cells. Am J Physiol 270 (2 Part 2): R326-R332.
25. Schummers J, Yu H, Sur M. 2008. Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex. Science 320:1638-1643.
26. Streit WJ. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139.
27. Turck J, Oberdorfer C, Vogel T, Mackenzie CR, Daubener W. 2005. Enhancement of antimicrobial effects by glucocorticoids. Med Microbiol Immunol (Berl) 194:47-53.
28. Volterra A, Meldolesi J. 2005. Astrocytes, from brain glue to communication elements: The revolution continues. Nat Rev Neurosci 6:626-640.
29. Wang J, Zhai Q, Chen Y, Lin E, Gu W, McBurney MW, He Z. 2005. A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 170:349-355.
30. Willis SA, Nisen PD. 1995. Inhibition of lipopolysaccharide-induced IL-1βtranscription by cyclic adenosine monophosphate in human astrocytic cells. J Immunol 154:1399-1406.